Mark Krueger & Associates, Inc.

We have a proven track record in achieving tangible results that enhance our clients' reputations and ensure their products' success in the marketplace. Here are just a few projects we have executed:

We helped a global pharmaceutical company create a balanced plan for pre-approval drug availability for a promising anti-cancer compound in a way that met the expectations of patients, professionals, and regulatory bodies around the world, all in record time, setting new standards for the industry.

For a European pharmaceutical company unfamiliar with the European patient advocacy environment, we created a phased outreach plan that introduced the company and its product to key influencers on the European and national levels, generating greater awareness and increasing regulatory attention.

Another client was thrown into crisis when the company discontinued its drug for multiple sclerosis because it underestimated the drug's demand for the treatment of infants with infantile spasms. We provided assistance with regulatory affairs, media relations, and patient and professional group relations. We also suggested a limited drug access program until production could be resumed. As a result, the company came to be viewed more favorably by medical professionals and regulatory agencies.

When a client discovered an important new indication for an established drug, we devised a high profile campaign on the efficacy and safety of the drug, including a program for patient-at-risk analysis and identification of advocates to help communicate the company's message. The company received accelerated marketing and labeling approval from the U.S. Food and Drug Administration.

When a highly anticipated drug's clinical results proved disappointing, our strategies enabled the drug's developer to avoid the spread of misinformation among advocates, patients, and physicians and brought the company favorable press in The Wall Street Journal and the New York Times.

For another client, we developed strategies to educate and involve patients and the advocacy community in the approval process for a new drug. The drug's maker received a Public Relations Society of America Big Apple Award and an Inside PR Creativity in Public Relations Award for the program.

We can also help your company form mutually beneficial partnerships with patient and professional advocacy groups and other key product influencers to help you reach your objectives.